*To schedule an appointment with Dr. Hildebrandt, please call at the practice at (212) 659-8838. My research interests span three major areas: (1) development and evaluation of clinical interventions for adolescents and adults with eating and weight disorders or adults with alcohol use disorders; (2) psychiatric and physical consequences of appearance and performance enhancing drug (APED) use or anabolic androgenic steroid (AAS)use; (3) the biological basis, especially the neuroendocrine and hormonal contributions to eating and substance use disorders. Treatment and Intervention: Currently this research involves developing novel therapeutic interventions based on exposure therapy for body image disturbances and the development of family based interventions for pediatric weight disorders, building of off the “Maudsley Method” which is a form of family therapy used to treat anorexia nervosa. APEDs and AASs: Currently our lab is conducting the first longitudinal study of APED use among active AAS users and seeks to characterize the desirable and undesirable changes that occur in psychological domains (e.g., body image, aggression, etc.), physical domains (e.g., increases in lean muscle mass), and along the hypothalamic-pituitary-gonadal or hypothalamic-pituitary-adrenal (HPA) axes. This research seeks to identify biomarkers of AAS dependence and ultimately to develop interventions and prevention programs for APED users. Hormones and Psychopathology: Currently our lab is interested in identifying the hormonal contributions to eating pathology, in part, to help explain the gender differences in prevalence rates of eating disorders and AAS use.

Education & experience

Education

Rutgers, The State University of New Jersey (PsyD)

Rutgers, The State University of New Jersey, Internship in Clinical Psychology

Practice

Mount Sinai FPA Psychiatry Department

Affiliation

The Mount Sinai Hospital

Awards and publications

Hildebrandt T, Bacow TL, Markella M, Loeb K. Theoretical mechanisms of action in family therapy for anorexia nervosa: Is there overlap with exposure therapy?. European Eating Disorders Review;.

Hildebrandt T, Yehuda R, Alfano L. What can allostasis tell us about anabolic-androgenic steroid use?. Development and Psychopathology;.

Sysko R, Hildebrandt T. Enhanced cognitive behavior therapy for purging disorder: a case study. European Eating Disorders Review;.

Sysko R, Hildebrandt T, Wilson GT, Wilfley DE, Agras WS. An examination of the diagnostic classification and short-term course of binge eating disorder using latent class and latent transition analyses. Journal of Consulting and Clinical Psychology;.

Hildebrandt T, Epstein E, McCrady B, Cook S. When should clinicians switch treatments: an application of signal detection theory to two different treatments for women with alcohol use disorders. Behavior Research and Therapy;.